MMP inhibition by chemically modified tetracycline-3 (CMT-3) in equine pulmonary epithelial lining fluid.
Department of Clinical Veterinary Sciences, Faculty of Veterinary Medicine, University of Helsinki, Finland. paivi.maisi@helsinki.fi
P
P
Maisi
M
M
Kiili
S M
SM
Raulo
E
E
Pirilä
T
T
Sorsa
D000818:Animals; D001826:Body Fluids / Q000201:enzymology*; D004847:Epithelial Cells / Q000166:cytology / Q000201:enzymology*; D005780:Gelatin / Q000378:metabolism; D006736:Horses; D006801:Humans; D007700:Kinetics; D020780:Matrix Metalloproteinase 9; D061965:Matrix Metalloproteinase Inhibitors; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D011480:Protease Inhibitors / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors; D013754:Tetracyclines / Q000494:pharmacology*; D014132:Trachea / Q000166:cytology / Q000201:enzymology*
D061965:Matrix Metalloproteinase Inhibitors; D011480:Protease Inhibitors; D011994:Recombinant Proteins; D013754:Tetracyclines; C117155:tetracycline CMT-3; D005780:Gelatin; D008666:Metalloendopeptidases; D020780:Matrix Metalloproteinase 9